Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Phase 3

Completed

• Conditions: Open-angle Glaucoma; Ocular Hypertension

• Registration Number: NCT00288951
• Lead Sponsor: Alcon Research

Brief Summary

The purpose of this study is to determine the safety and IOP-lowering ability of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension

Detailed Description

Not available

Study Timeline

• Study Start: 2004-10
• Primary Completion: 2005-06
• Study Completion: 2005-06
• Study First Submitted: 2006-02-07
• Study First Submitted QC: 2006-02-07
• Study First Posted: 2006-02-09
• Status Verified: 2009-09
• Last Update Submitted: 2012-08-16
• Last Update Posted: 2012-08-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 690

Inclusion Criteria

• Adult subjects of either sex and any race 18 years or older with open-angle glaucoma or ocular hypertension. Patients with logMAR visual acuity not worse than 0.6 in either eye or any clinically relevant ophthalmic/systemic condition will be excluded.

Exclusion Criteria

• See Inclusion Criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL